{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["55"],"submitter":["Biancari F"],"pubmed_abstract":["<h4>Background</h4>The evidence of the long-term advantages of transcatheter aortic valve replacement (TAVR) over surgical aortic valve replacement (SAVR) for aortic stenosis (AS) remains scarce.<h4>Methods</h4>Patients with EuroSCORE II < 4 % who underwent TAVR or SAVR for AS from the prospective observational OBSERVANT study were included in this analysis. Ten-year survival was the primary outcome of this analysis. Secondary outcome was repeat procedure on the aortic valve prosthesis.<h4>Results</h4>Propensity score matching resulted in 355 matched pairs of patients who underwent TAVR or SAVR. The mean age of SAVR patients was 80.0 ± 5.1 years and that of TAVR patients 80.1 ± 6.4 years (p = 0.81) and the mean EuroSCORE II was 2.5 ± 0.8 % and 2.6 ± 0.8 % (p = 0.60), respectively. Thirty-d"],"journal":["International journal of cardiology. Heart & vasculature"],"pagination":["101545"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11567919"],"repository":["biostudies-literature"],"pubmed_title":["Ten-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients: The OBSERVANT study."],"pmcid":["PMC11567919"],"pubmed_authors":["Baglio G","Badoni G","Biancari F","Polvani G","Rosato S","D'Errigo P","Costa G","Barbanti M","Tamburino C"],"additional_accession":[]},"is_claimable":false,"name":"Ten-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients: The OBSERVANT study.","description":"<h4>Background</h4>The evidence of the long-term advantages of transcatheter aortic valve replacement (TAVR) over surgical aortic valve replacement (SAVR) for aortic stenosis (AS) remains scarce.<h4>Methods</h4>Patients with EuroSCORE II < 4 % who underwent TAVR or SAVR for AS from the prospective observational OBSERVANT study were included in this analysis. Ten-year survival was the primary outcome of this analysis. Secondary outcome was repeat procedure on the aortic valve prosthesis.<h4>Results</h4>Propensity score matching resulted in 355 matched pairs of patients who underwent TAVR or SAVR. The mean age of SAVR patients was 80.0 ± 5.1 years and that of TAVR patients 80.1 ± 6.4 years (p = 0.81) and the mean EuroSCORE II was 2.5 ± 0.8 % and 2.6 ± 0.8 % (p = 0.60), respectively. Thirty-d","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Dec","modification":"2025-04-03T23:23:42.491Z","creation":"2025-04-03T23:23:42.491Z"},"accession":"S-EPMC11567919","cross_references":{"pubmed":["39555490"],"doi":["10.1016/j.ijcha.2024.101545"]}}